alternative glp-1 medication A new FDA-approved obesity pill could offer a lower-cost to injectable drugs like Ozempic and Mounjaro. In a major clinical trial, people taking the highest dose lost about 11% of GLP-1 analogs, new trend in

That pattern has prompted researchers to explore whether adding even more targets, or fine-tuning the balance between existing ones, could push results further still

Any general advice posted on our blog, website, or app is for informational purposes only and is not intended to replace or substitute for any medical or other advice

The SUPRPASS-4 trial (262), involving 2002 participants with high-risk cardiovascular profiles followed for up to 104 weeks, showed no difference in 4-MACE events (cardiovascular death, myocardial infarction, stroke, and hospitalization for unstable angina) with tirzepatide compared to insulin glargine (HR 0.74

GLP-1 drops for beginners: your first two weeks Starting GLP-1 drops can feel overwhelming